COMMUNIQUÉS West-GlobeNewswire

Marble Announces its First Vice President of Sales
10/07/2025
Appoints Software-as-a-Service Industry Veteran Brendan Callaghan Toronto, Ontario, July 10, 2025 (GLOBE NEWSWIRE) -- Marble , the unified health data platform transforming how businesses access, aggregate and analyze [...]
Tonix Pharmaceuticals Announces Presentation of New Data on Mpox and Smallpox Vaccine Candidate TNX-801 at the Vaccine Congress 2025
10/07/2025
TNX-801 is up to 100,000-fold less virulent than live smallpox vaccine strains and a single dose provides robust immunogenicity and protection against mpox and rabbitpox (more than one year) in animals Subcutaneous [...]
Biogen and Stoke Therapeutics Announce Presentation of Data from Studies of Zorevunersen, an Investigational Medicine for Dravet syndrome, at the 16th European Paediatric Neurology Society (EPNS) Congress
10/07/2025
– Data from an analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed improvements in cognition and behavior at Week 68 – – These findings support the inclusion of key [...]
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
10/07/2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) is pleased to announce the expansion of its HealthTab™ platform into pharmacies in North [...]
Pharvaris Updates Timing of Topline Data Announcement for RAPIDe-3 Pivotal Phase 3 Study to the Fourth Quarter of 2025
10/07/2025
Company expects to submit deucrictibant IR capsule NDA to the U.S. FDA for the on-demand treatment of HAE attacks in 1H2026 ZUG, Switzerland, July 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage [...]
Rhythm Pharmaceuticals, Inc. Announces Pricing of Upsized Public Offering of Common Stock
10/07/2025
BOSTON, July 10, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare [...]
Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock
10/07/2025
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq:SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Soleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025
10/07/2025
REDWOOD CITY, Calif., July 10, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (Nasdaq: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform
10/07/2025
- Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors Rome, Italy, 10 th July 2025 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing [...]
Osivax Publishes Phase 2a Results Supporting Co-Administration of OVX836 with Seasonal Flu Vaccine in Vaccines Journal
10/07/2025
Co-administration of OVX836 with seasonal inactivated influenza vaccine (Fluarix ® Tetra) was well-tolerated and demonstrated a favorable safety profile Robust complementary immune responses were induced, with no major [...]
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
10/07/2025
REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of [...]
Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer
10/07/2025
REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the [...]
Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
10/07/2025
CAMBRIDGE, United Kingdom and MONTREAL, July 10, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the [...]
Epitopea renforce ses capacités de recherche et de développement clinique pour accélérer le passage à la clinique
10/07/2025
CAMBRIDGE, Royaume-Uni et MONTRÉAL, 10 juill. 2025 (GLOBE NEWSWIRE) -- Epitopea, société transatlantique d'immunothérapie anticancéreuse développant des immunothérapies à base d'ARN accessibles et prêtes à l'emploi, a [...]
Rakovina Therapeutics Highlights Strength of Scientific Advisory Board Driving Innovation in AI-Enabled Oncology Drug Development
10/07/2025
VANCOUVER, British Columbia, July 10, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer therapies [...]
New Bay Area Lyme Foundation Study Reports That Only One-Third of Early Lyme Patients with On-Going Symptoms Followed up with their Healthcare Providers
10/07/2025
The new research, published in Frontiers in Medicine, points to the need for greater follow-up from medical professionals to address potential treatment failures. PORTOLA VALLEY, Calif., July 10, 2025 (GLOBE NEWSWIRE [...]
DXS International plc (AQSE:DXSP): ExpertCare featured in Innovate UK Research Project
10/07/2025
DXS INTERNATIONAL PLC (AQSE: DXSP) ExpertCare featured in Innovate UK Research Project DXS International plc ("DXS" or "the Company"), a leading provider of digital clinical decision support solutions, is thrilled to [...]
Tecan announces CEO transition as part of succession planning
10/07/2025
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, July 10, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned CEO transition, [...]
Gozellix Receives Permanent HCPCS Code
10/07/2025
MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA 1 PET 2 imaging agent, Gozellix® (kit [...]

Pages